European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase inhibitors, mandate regular updating of concepts and management. A European LeukemiaNet expert panel reviewed prior and new studies to update recommendations made in 2009. We recommend as initial treatment imatini...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Blood
Main Authors: Baccarani, Michele, Deininger, Michael W., Rosti, Gianantonio, Hochhaus, Andreas, Soverini, Simona, Apperley, Jane F., Cervantes, Francisco, Clark, Richard E., Cortes, Jorge E., Guilhot, François, Hjorth-Hansen, Henrik, Hughes, Timothy P., Kantarjian, Hagop M., Kim, Dong-Wook, Larson, Richard A., Lipton, Jeffrey H., Mahon, François-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Pane, Fabrizio, Radich, Jerald P., Rousselot, Philippe, Saglio, Giuseppe, Saußele, Susanne, Schiffer, Charles, Silver, Richard, Simonsson, Bengt, Steegmann, Juan-Luis, Goldman, John M., Hehlmann, Rüdiger
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2013
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915804/
https://ncbi.nlm.nih.gov/pubmed/23803709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-05-501569
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki